The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2019

Filed:

May. 23, 2013
Applicant:

The Ohio State University, Columbus, OH (US);

Inventors:

Robert J. Lee, Columbus, OH (US);

Young Bok Lee, Clarksburg, MD (US);

Deog Joong Kim, Rockville, MD (US);

Chang Ho Ahn, Potomac, MD (US);

Assignee:

The Ohio State University, Columbus, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2006.01); A61K 45/06 (2006.01); A61K 9/127 (2006.01); A61K 31/7088 (2006.01); C12N 15/113 (2010.01); A61K 31/713 (2006.01); A61K 47/64 (2017.01); A61K 38/10 (2006.01); A61K 38/48 (2006.01); C07K 16/00 (2006.01); A61K 47/54 (2017.01); A61K 47/59 (2017.01); A61K 47/69 (2017.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/643 (2017.08); A61K 9/127 (2013.01); A61K 9/1271 (2013.01); A61K 9/1272 (2013.01); A61K 31/7088 (2013.01); A61K 31/713 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/482 (2013.01); A61K 45/06 (2013.01); A61K 47/543 (2017.08); A61K 47/59 (2017.08); A61K 47/6911 (2017.08); C07K 16/00 (2013.01); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); C12N 15/1137 (2013.01); A61K 48/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12Y 304/21064 (2013.01);
Abstract

Described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a targeting agent. The composition can include a therapeutic agent. The therapeutic agent can be an antisense oligonucleotide (ASO). Exemplary ASOs are targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1; or targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Also described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a therapeutic agent that is an ASO such as an ASO targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1 or an ASO targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Pharmaceutical formulations, methods of making the lipid nanoparticles, and methods of using the lipid nanoparticles, for example for treating cancers, are also disclosed.


Find Patent Forward Citations

Loading…